Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Exp Hematol

Retrieve available abstracts of 67 articles:
HTML format
Text format



Single Articles


    March 2017
  1. GHOSH J, Kapur R
    Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
    Exp Hematol. 2017 Mar 22. pii: S0301-472X(17)30063.
    PubMed     Text format     Abstract available


    February 2017
  2. CAO H, Xu Y, de Necochea-Campion R, Baylink DJ, et al
    Application of vitamin D and vitamin D analogs in acute myelogenous leukemia.
    Exp Hematol. 2017 Feb 4. pii: S0301-472X(17)30050.
    PubMed     Text format     Abstract available


    January 2017
  3. CANDONI A, De Marchi F, Zanini F, Zannier ME, et al
    Predictive value of pre transplant molecular minimal residual disease assessment by wt1 gene expression in flt3 positive acute myeloid leukemia.
    Exp Hematol. 2017 Jan 31. pii: S0301-472X(17)30015.
    PubMed     Text format     Abstract available


    December 2016
  4. ORTI G, Barba P, Fox L, Salamero O, et al
    Donor Lymphocyte Infusions in AML and MDS: enhancing the Graft-versus-Leukemia effect.
    Exp Hematol. 2016 Dec 24. pii: S0301-472X(16)30772.
    PubMed     Text format    


    November 2016
  5. CHURCHMAN ML, Mullighan CG
    Ikaros: exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.
    Exp Hematol. 2016 Nov 16. pii: S0301-472X(16)30703.
    PubMed     Text format     Abstract available


  6. ZHOU X, Li Z, Zhou J
    TNF-alpha in onset and progression of leukemia.
    Exp Hematol. 2016 Nov 7. pii: S0301-472X(16)30660.
    PubMed     Text format     Abstract available


  7. LEMOLI RM, Parisi S, Curti A
    Novel Strategies of Adoptive Immunotherapy: How Natural Killer Cells May Change the Treatment of Elderly Patients With Acute Myeloblastic Leukemia.
    Exp Hematol. 2016 Nov 5. pii: S0301-472X(16)30662.
    PubMed     Text format     Abstract available


    October 2016
  8. DWIVEDI P, Greis KD
    Granulocyte Colony Stimulating Factor Receptor (G-CSFR) signaling in severe congenital neutropenia, chronic neutrophilic leukemia and related malignancies.
    Exp Hematol. 2016 Oct 24. pii: S0301-472X(16)30663.
    PubMed     Text format     Abstract available


  9. ZHOU L, Wang Q, Chen X, Fu L, et al
    AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia.
    Exp Hematol. 2016 Oct 7. pii: S0301-472X(16)30649.
    PubMed     Text format     Abstract available


  10. DEVEAU AP, Bentley VL, Berman JN
    Using zebrafish models of leukemia to streamline drug screening and discovery.
    Exp Hematol. 2016 Oct 6. pii: S0301-472X(16)30648.
    PubMed     Text format     Abstract available


    September 2016
  11. YANAGISAWA B, Ghiaur G, Smith BD, Jones RJ, et al
    Translating Leukemia Stem Cells into the Clinic: Harmonizing the Heterogeneity.
    Exp Hematol. 2016 Sep 28. pii: S0301-472X(16)30572.
    PubMed     Text format     Abstract available


  12. BASHFORD-ROGERS RJ, Palser AL, Hodkinson C, Baxter J, et al
    Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
    Exp Hematol. 2016 Sep 28. pii: S0301-472X(16)30622.
    PubMed     Text format     Abstract available


  13. PARK M, Park CJ, Cho YW, Jang S, et al
    Alterations in bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia and normal bone marrow.
    Exp Hematol. 2016 Sep 27. pii: S0301-472X(16)30621.
    PubMed     Text format     Abstract available


  14. WEIDEMANN RR, Behrendt R, Schoedel KB, Muller W, et al
    Constitutive Kit activity triggers B cell acute lymphoblastic leukemia-like disease in mice.
    Exp Hematol. 2016 Sep 21. pii: S0301-472X(16)30615.
    PubMed     Text format     Abstract available


  15. SCHNEIDER E, Staffas A, Rohner L, Krowiorz K, et al
    MicroRNA-155 is upregulated in MLL rearranged AML but its absence does not affect leukemia development.
    Exp Hematol. 2016 Sep 9. pii: S0301-472X(16)30597.
    PubMed     Text format     Abstract available


    July 2016
  16. LAVERDIERE I, Boileau M, Herold T, Rak J, et al
    Complement Cascade Gene Expression Defines Novel Prognostic Subgroups of Acute Myeloid Leukemia.
    Exp Hematol. 2016 Jul 26. pii: S0301-472X(16)30514.
    PubMed     Text format    


  17. RUCKER-BRAUN E, Link CS, Schmiedgen M, Tunger A, et al
    Longitudinal analyses of leukemia-associated antigen-specific CD8+ T cells in patients after allogeneic stem cell transplantation.
    Exp Hematol. 2016 Jul 26. pii: S0301-472X(16)30510.
    PubMed     Text format     Abstract available


  18. ZHAO L, Eric So CW
    PARP-inhibitor-induced synthetic lethality for acute myeloid leukemia treatment.
    Exp Hematol. 2016 Jul 26. pii: S0301-472X(16)30509.
    PubMed     Text format     Abstract available


    June 2016
  19. KOJIMA K, Ishizawa J, Andreeff M
    Pharmacological activation of wild-type p53 in the therapy of leukemia.
    Exp Hematol. 2016 Jun 17. pii: S0301-472X(16)30139.
    PubMed     Text format     Abstract available


    May 2016
  20. ECKSTEIN OS, Wang L, Punia JN, Kornblau SM, et al
    Mixed Phenotype Acute Leukemia (MPAL) Exhibits Frequent Mutations in DNMT3A and Activated Signaling Genes.
    Exp Hematol. 2016 May 18. pii: S0301-472X(16)30128.
    PubMed     Text format     Abstract available


  21. GRIFFITH M, Griffith OL, Krysiak K, Skidmore ZL, et al
    Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B lymphoblastic leukemia.
    Exp Hematol. 2016 May 12. pii: S0301-472X(16)30115.
    PubMed     Text format     Abstract available


  22. KADONO M, Kanai A, Nagamachi A, Shinriki S, et al
    Biological implications of somatic DDX41 p.R525H mutation in acute myeloid leukemia.
    Exp Hematol. 2016 May 9. pii: S0301-472X(16)30125.
    PubMed     Text format     Abstract available


  23. ZHANG J, Liu X, Lin Y, Li Y, et al
    HnRNP K contributes to drug resistance in acute myeloid leukemia through the regulation of autophagy.
    Exp Hematol. 2016 May 4. pii: S0301-472X(16)30118.
    PubMed     Text format     Abstract available


  24. YANG YG, Sari IN, Zia MF, Lee SR, et al
    Tetraspanins: Spanning from solid tumors to hematologic malignancies.
    Exp Hematol. 2016;44:322-8.
    PubMed     Text format     Abstract available


  25. BOSSE RC, Wasserstrom B, Meacham A, Wise E, et al
    Chemosensitizing AML cells by targeting bone marrow endothelial cells.
    Exp Hematol. 2016;44:363-377.
    PubMed     Text format     Abstract available


    April 2016
  26. RIEGER CT, Fiegl M
    Microenvironmental oxygen partial pressure in acute myeloid leukemia: is there really a role for hypoxia?
    Exp Hematol. 2016 Apr 23. pii: S0301-472X(16)30082.
    PubMed     Text format     Abstract available


  27. BYRNE M, Savani BN, Mohty M, Nagler A, et al
    Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Exp Hematol. 2016 Apr 19. pii: S0301-472X(16)30077.
    PubMed     Text format     Abstract available


    March 2016
  28. WANG QY, Zhong H, Chen FY, Zhang MY, et al
    A preliminary study on epigenetic regulation of Acanthopanax senticosus in leukemia cell lines.
    Exp Hematol. 2016 Mar 15. pii: S0301-472X(16)30031.
    PubMed     Text format     Abstract available


  29. HOOFD C, Wang X, Lam S, Jenkins C, et al
    CD44 promotes chemoresistance in T-ALL by increased drug efflux.
    Exp Hematol. 2016;44:166-71.
    PubMed     Text format     Abstract available


  30. ISHIBASHI T, Yaguchi A, Terada K, Ueno-Yokohata H, et al
    Ph-like ALL-related novel fusion kinase ATF7IP-PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells.
    Exp Hematol. 2016;44:177-88.
    PubMed     Text format     Abstract available


    February 2016
  31. KUO YH, Qi J, Cook GJ
    Regain control of p53: targeting leukemia stem cells by isoform-specific HDAC inhibition.
    Exp Hematol. 2016 Feb 25. pii: S0301-472X(16)00071.
    PubMed     Text format     Abstract available


  32. CERABONA D, Sun Z, Nalepa G
    Leukemia and chromosomal instability in aged Fancc-/- mice.
    Exp Hematol. 2016 Feb 6. pii: S0301-472X(16)00038.
    PubMed     Text format     Abstract available


  33. PIZZO RJ, Azadniv M, Guo N, Acklin J, et al
    Phenotypic, Genotypic, and Functional Characterization of Normal and Acute Myeloid Leukemia-Derived Marrow Endothelial Cells.
    Exp Hematol. 2016 Feb 3. pii: S0301-472X(16)00037.
    PubMed     Text format     Abstract available


  34. SCHMOHL J, Santovito D, Guenther T, Sutanto W, et al
    Expression of surface-associated 82kDa-proMMP-9 in primary acute leukemia blast cells inversely correlates with patients' risk.
    Exp Hematol. 2016 Feb 1. pii: S0301-472X(16)00036.
    PubMed     Text format     Abstract available


    January 2016
  35. CHEN WS, Zhu HH, Feng GS
    Treating Leukemia at Risk of Inducing Severe Anemia.
    Exp Hematol. 2016 Jan 27. pii: S0301-472X(16)00033.
    PubMed     Text format     Abstract available


  36. ISHIBASHI T, Yokota T, Tanaka H, Ichii M, et al
    ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.
    Exp Hematol. 2016 Jan 13. pii: S0301-472X(16)00005.
    PubMed     Text format     Abstract available


    December 2015
  37. SUN WT, Xiang W, Ng BL, Asari K, et al
    Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia.
    Exp Hematol. 2015 Dec 17. pii: S0301-472X(15)00799.
    PubMed     Text format     Abstract available


  38. DOLNIKOV A, Shen S, Klamer G, Joshi S, et al
    Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia.
    Exp Hematol. 2015;43:1001-1014.
    PubMed     Text format     Abstract available


    November 2015
  39. TZORAN I, Rebibo-Sabbah A, Brenner B, Aharon A, et al
    Disease dynamics in patients with acute myeloid leukemia: new biomarkers.
    Exp Hematol. 2015;43:936-43.
    PubMed     Text format     Abstract available


  40. NAKAMURA D, Yoshimitsu M, Kuroki A, Hachiman M, et al
    A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.
    Exp Hematol. 2015;43:944-50.
    PubMed     Text format     Abstract available


  41. DANIS E, Yamauchi T, Echanique K, Haladyna J, et al
    Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.
    Exp Hematol. 2015;43:930-935.
    PubMed     Text format     Abstract available


    October 2015
  42. SYKES SM, Kokkaliaris KD, Milsom MD, Levine RL, et al
    Clonal evolution of pre-leukemic hematopoietic stem cells in acute myeloid leukemia.
    Exp Hematol. 2015 Oct 8. pii: S0301-472X(15)00659.
    PubMed     Text format     Abstract available


  43. SHUKLA A, Cutucache CE, Sutton GL, Pitner MA, et al
    Absence of Caveolin-1 Leads to Delayed Development of Chronic Lymphocytic Leukemia in Emu-TCL1 Mouse Model.
    Exp Hematol. 2015 Oct 1. pii: S0301-472X(15)00671.
    PubMed     Text format     Abstract available


  44. MANUKJAN G, Ripperger T, Santer L, von Neuhoff N, et al
    Expression of the ETS transcription factor GABPalpha is positively correlated to the BCR-ABL1/ABL1 ratio in CML patients and affects imatinib sensitivity in vitro.
    Exp Hematol. 2015;43:880-90.
    PubMed     Text format     Abstract available


  45. KING KY, Matatall KA, Shen CC, Goodell MA, et al
    Comparative long-term effects of interferon alpha and hydroxyurea on human hematopoietic progenitor cells.
    Exp Hematol. 2015;43:912-918.
    PubMed     Text format     Abstract available


    September 2015
  46. MOSES BS, Slone WL, Thomas P, Evans R, et al
    Bone Marrow Microenvironment Modulation of Acute Lymphoblastic Leukemia Phenotype.
    Exp Hematol. 2015 Sep 22. pii: S0301-472X(15)00664.
    PubMed     Text format     Abstract available


  47. SAUER T, Arteaga MF, Isken F, Rohde C, et al
    MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML.
    Exp Hematol. 2015;43:794-802.
    PubMed     Text format     Abstract available


  48. CHAUDHURY SS, Morison JK, Gibson BE, Keeshan K, et al
    Insights into cell ontogeny, age, and acute myeloid leukemia.
    Exp Hematol. 2015;43:745-55.
    PubMed     Text format     Abstract available


    August 2015
  49. EKETORP SYLVAN S, Skribek H, Norin S, Muhari O, et al
    Sensitivity of chronic lymphocytic leukemia cells to small targeted therapeutic molecules: an in vitro comparative study.
    Exp Hematol. 2015 Aug 28. pii: S0301-472X(15)00630.
    PubMed     Text format     Abstract available


  50. CAOCCI G, Martino B, Greco M, Abruzzese E, et al
    Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients.
    Exp Hematol. 2015 Aug 22. pii: S0301-472X(15)00611.
    PubMed     Text format     Abstract available


  51. NAKAMAE H, Koh H, Katayama T, Nishimoto M, et al
    HLA haplo-identical peripheral blood stem cell transplantation using reduced dose of post-transplantation cyclophosphamide for poor prognosis or refractory leukemia and myelodysplastic syndrome.
    Exp Hematol. 2015 Aug 15. pii: S0301-472X(15)00568.
    PubMed     Text format     Abstract available


    July 2015
  52. BASHEER F, Huntly BJ
    BET Bromodomain Inhibitors in leukemia.
    Exp Hematol. 2015 Jul 8. pii: S0301-472X(15)00212.
    PubMed     Text format     Abstract available


  53. GENTNER B, Pochert N, Rouhi A, Boccalatte F, et al
    MicroRNA-223 dose-levels fine-tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
    Exp Hematol. 2015 Jul 8. pii: S0301-472X(15)00511.
    PubMed     Text format     Abstract available


  54. NANDAKUMAR SK, Johnson K, Throm SL, Pestina TI, et al
    Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
    Exp Hematol. 2015;43:565-77.
    PubMed     Text format     Abstract available


    June 2015
  55. DURINCK K, Goossens S, Peirs S, Wallaert A, et al
    Novel biological insights in T-cell acute lymphoblastic leukemia.
    Exp Hematol. 2015 Jun 26. pii: S0301-472X(15)00211.
    PubMed     Text format     Abstract available


  56. CHEN CW, Armstrong SA
    Targeting DOT1L and HOX Gene Expression in MLL-Rearranged Leukemia and Beyond.
    Exp Hematol. 2015 Jun 25. pii: S0301-472X(15)00194.
    PubMed     Text format     Abstract available


  57. DKHISSI F, Aggoune D, Pontis J, Sorel N, et al
    The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in Chronic Myeloid Leukemia.
    Exp Hematol. 2015 Jun 25. pii: S0301-472X(15)00165.
    PubMed     Text format     Abstract available


  58. ERIKSSON A, Lennartsson A, Lehmann S
    Epigenetic aberrations in acute myeloid leukemia: early key events during leukemogenesis.
    Exp Hematol. 2015 Jun 25. pii: S0301-472X(15)00191.
    PubMed     Text format     Abstract available


  59. GHAZAVI F, Lammens T, Van Roy N, Poppe B, et al
    The molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia.
    Exp Hematol. 2015 Jun 19. pii: S0301-472X(15)00209.
    PubMed     Text format     Abstract available


  60. MANNELLI F, Ponziani V, Bonetti MI, Bencini S, et al
    Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia.
    Exp Hematol. 2015 Jun 19. pii: S0301-472X(15)00208.
    PubMed     Text format     Abstract available


  61. VALDEZ BC, Li Y, Murray D, Ji J, et al
    Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.
    Exp Hematol. 2015;43:448-61.
    PubMed     Text format     Abstract available


    May 2015
  62. IIZUKA H, Kagoya Y, Kataoka K, Yoshimi A, et al
    Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
    Exp Hematol. 2015 May 25. pii: S0301-472X(15)00170.
    PubMed     Text format     Abstract available


  63. ORFALI N, O'Donovan TR, Nyhan MJ, Britschgi A, et al
    Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacological modulation.
    Exp Hematol. 2015 May 15. pii: S0301-472X(15)00164.
    PubMed     Text format     Abstract available


  64. GASIOREK JJ, Mikhael M, Garcia-Santos D, Hui ST, et al
    Thioredoxin-interacting protein regulates the differentiation of murine erythroid precursors.
    Exp Hematol. 2015;43:393-403.
    PubMed     Text format     Abstract available


    April 2015
  65. TOGAMI K, Kitaura J, Uchida T, Inoue D, et al
    A C-terminal mutant of CCAAT-enhancer-binding protein alpha (C/EBPalpha-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPalpha-Cm.
    Exp Hematol. 2015;43:300-8.
    PubMed     Text format     Abstract available


    March 2015
  66. KUMMALUE T, Inoue T, Miura Y, Narusawa M, et al
    Ribosomal protein L11 and retinol dehydrogenase 11 induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells.
    Exp Hematol. 2015 Mar 27. pii: S0301-472X(15)00035.
    PubMed     Text format     Abstract available


  67. YAMANISHI M, Narazaki H, Asano T
    Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase.
    Exp Hematol. 2015;43:207-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: